PMID- 21161416 OWN - NLM STAT- MEDLINE DCOM- 20110428 LR - 20240412 IS - 1689-1392 (Electronic) IS - 1425-8153 (Print) IS - 1425-8153 (Linking) VI - 16 IP - 1 DP - 2011 Mar TI - Endothelial microparticle formation in moderate concentrations of homocysteine and methionine in vitro. PG - 69-78 LID - 10.2478/s11658-010-0040-2 [doi] AB - Microparticles (MPs) are small membrane vesicles released by stimulated or apoptotic cells, including the endothelium. Hyperhomocysteinemia (HHcy) is a blood disorder characterized by an increase in the plasma concentrations of total homocysteine (Hcy). The plasma Hcy level is determined by environmental factors (dietary habits, i.e. the intake of folic acid, FA) and genetic factors (N (5),N (10)-methylenetetrahydro-folate reductase, MTHFR, polymorphism 677C>T). To evaluate whether moderate Hcy concentrations induce endothelial MP formation, the role of FA supplementation and the influence of MTHFR polymorphism were analysed. Human umbilical vein endothelial cells (HUVEC) were treated in vitro with 50 muM of Hcy and methionine (Met). The MP number and apoptotic phenotype were analyzed using flow cytometry. Increasing doses of FA (5, 15 and 50 muM) were used to reduce the HHcy effect. The MTHFR 677C>T polymorphism was determined. HUVEC stimulated by Hcy produced significantly more MPs than HUVEC under the control conditions: 3,551 +/- 620 vs 2,270 +/- 657 kMP (p = 0.02). Supplementation with FA at concentrations of 5, 15 and 50 muM reduced the MP count in the cell culture supernatant to 345 +/- 332, 873 +/- 329, and 688 +/- 453 kMP, respectively (p = 0.03). MTHFR 677C>T heterozygosity was associated with a significant increase in MP formation after stimulation with Hcy compared to the control conditions: 3,617 +/- 152 vs 1,518 +/- 343 kMP (p = 0.02). Furthermore, the MTHFR genotype altered MP formation after Met loading. On average, 24% of the entire MP population was apoptotic (annexin V-positive). Endothelial function impairment due to HHcy is related to MP shedding, which may involve platelets and other blood and vascular cells. MP shedding is a physiological response to moderate HHcy. FAU - Sekula, Malgorzata AU - Sekula M AD - Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland. FAU - Janawa, Greta AU - Janawa G FAU - Stankiewicz, Elzbieta AU - Stankiewicz E FAU - Stepien, Ewa AU - Stepien E LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20101215 PL - England TA - Cell Mol Biol Lett JT - Cellular & molecular biology letters JID - 9607427 RN - 0LVT1QZ0BA (Homocysteine) RN - 935E97BOY8 (Folic Acid) RN - AE28F7PNPL (Methionine) RN - EC 1.5.1.20 (Methylenetetrahydrofolate Reductase (NADPH2)) SB - IM MH - Apoptosis MH - Cell-Derived Microparticles/*metabolism MH - Endothelial Cells/*metabolism MH - Endothelium, Vascular/cytology MH - Flow Cytometry MH - Folic Acid/pharmacology MH - Genotype MH - Homocysteine/*pharmacology MH - Humans MH - Methionine/*pharmacology MH - Methylenetetrahydrofolate Reductase (NADPH2)/genetics MH - Polymorphism, Single Nucleotide MH - Umbilical Cord/cytology PMC - PMC6275923 EDAT- 2010/12/17 06:00 MHDA- 2011/04/29 06:00 PMCR- 2010/12/15 CRDT- 2010/12/17 06:00 PHST- 2010/08/30 00:00 [received] PHST- 2010/12/01 00:00 [accepted] PHST- 2010/12/17 06:00 [entrez] PHST- 2010/12/17 06:00 [pubmed] PHST- 2011/04/29 06:00 [medline] PHST- 2010/12/15 00:00 [pmc-release] AID - 40 [pii] AID - 10.2478/s11658-010-0040-2 [doi] PST - ppublish SO - Cell Mol Biol Lett. 2011 Mar;16(1):69-78. doi: 10.2478/s11658-010-0040-2. Epub 2010 Dec 15.